Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
IMA · NASDAQ · Biological Products, (No Diagnostic Substances)
$3.92−0.06 (−1.51%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Imagenebio (IMA) · oqro.io/stocks/IMA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Cable Car Capital, LP disclosed an increased position in IMA for Q2 2026SourceInsider trade · Traded Jul 16, 2026 · Filed Jul 21, 2026
Officer sold ~$9.2K of IMA shares in the open marketSourceInsider trade · Traded Jul 17, 2026 · Filed Jul 21, 2026
Officer sold ~$8.1K of IMA shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Cable Car Capital, LP disclosed an increased position in IMA for Q1 2026SourceInsider trade · Traded Dec 24, 2025 · Filed Dec 29, 2025
Director purchased ~$96K of IMA shares in the open marketSourceInsider trade · Traded Jul 25, 2025 · Filed Jul 30, 2025
Director purchased ~$8M of IMA shares in the open marketSourceInsider trade · Traded Jul 25, 2025 · Filed Jul 30, 2025
Director purchased ~$2.5M of IMA shares in the open marketSource